P300 and symptom improvement in schizophrenia

Psychopharmacology

Volumn 158, Issue 1, 2001, Pages 55-65

  Ambrosino, N ^a   Simonds, A K ^a  

^a IRCCS   (Italy)

Author keywords

Atypical neuroleptics; Dipole source analysis; Longitudinal study; P300; Schizophrenia

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT; OLANZAPINE;

ADULT; AMPLITUDE MODULATION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIPOLE; DOUBLE BLIND PROCEDURE; ELECTRODE; EVOKED AUDITORY RESPONSE; FEMALE; HUMAN; LONGITUDINAL STUDY; MALE; MODEL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SCHIZOPHRENIA; SPIKE WAVE; SYMPTOMATOLOGY; AGE; BRAIN REGION; RELIABILITY; SEX DIFFERENCE; SYMPTOM; TREATMENT OUTCOME;

ADULT; AFFECTIVE SYMPTOMS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CLOZAPINE; DOUBLE-BLIND METHOD; EVENT-RELATED POTENTIALS, P300; FEMALE; FRONTAL LOBE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PARIETAL LOBE; PIRENZEPINE; SCHIZOPHRENIA; STATISTICS, NONPARAMETRIC;

EID: 0034794770     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130100835     Document Type: Article

References (69)

1. Premorbid functioning, cognitive functioning, symptoms and outcome in schizophrenia
2. Changes in auditory P3 event-related potential in schizophrenia and depression
3. Stress, anxiety and and event related potentials
4. Study of auditory event-related potentials recorded during a two-tone discrimination task in a group of 50 chronic schizophrenics
5. P300 delay and attenuation in schizophrenia: Reversal by neuroleptic medication
6. Molecular pathology of schizophrenia: More than one disease process
7. The P300 metric in schizophrenia: Effects of probability and modality
8. Ereigniskorrelierte hirnpotentiale und primäre negativsymptomatik bei schizophrenen patienten
9. P300, clinical symptoms, and neuropsychological parameters in acute and remitted schizophrenia: A preliminary report
10. P3 and schizophrenia
11. Schizophrenics have fewer and smaller P300s: A single-trial analysis
12. ERPs in schizophrenia: Effects of anti-psychotic medication
13. P300 amplitude is related to clinical state in severely and moderately I11 patients with schizophrenia
14. Endogenous scalp-recorded brain potentials in schizophrenia: A methodological review
15. P300 subcomponents reflect different aspects of psychopathology in schizophrenia
16. Dipole localization of P300 and normal aging
17. Dipole source analysis. Linking scalp potentials to their generating neuronal structures
18. Attentional performance in positive-and negative-symptom schizophrenia
19. Increased distractibility in schizophrenic patients. Electrophysiologic and behavioral evidence
20. Effects of task relevance and attention on P3 in schizophrenic patients
21. Event-related potentials in psychiatry
22. Dipole source analysis of P300 component of the auditory evoked potential: A methodological advance?
23. Schizophrenics with small P300: A subgroup with a neurodevelopmental disturbance and a high risk for tardive dyskinesia?
24. Event-related potential abnormalities and clinical syndromes in schizophrenics
25. P300 and the thought disorder factor extracted by factor-analytic procedures in schizophrenia
26. Electrical signs of selective attention in the human brain
27. Residual symptoms and P300 in schizophrenic outpatients
28. Reduced auditory P300 amplitude, medial temporal volume reduction and psychopathology in schizophrenia
29. The positive and negative syndrome scale (PANSS) for schizophrenia
30. The P300 potential in schizophrenia
31. Auditory event-related potentials and clinical scores in unmedicated schizophrenic patients
32. Differences between paranoid and nonparanoid schizophrenic patients on the somatosensory P300 event-related potential
33. Amplitude and area of the auditory P300 recorded with eyes open reflect remission of schizophrenia
34. Trait and state aspects of P300 amplitude reduction in schizophrenia: A retrospective longitudinal study
35. Auditory P300 abnormalities and left posterior superior temporal gyrus volume reduction in schizophrenia
36. P300 responses to novel auditory stimuli in hospitalized schizophrenic patients
37. Event-related potential indices of selective attention and cortical lateralization in schizophrenia
38. Assessment of enduring deficit and negative symptom subtypes in schizophrenia
39. A neurodevelopmental approach to the classification of schizophrenia
40. The auditory N2 component in schizophrenia: Relationship to MRI temporal lobe gray matter and to other ERP abnormalities
41. The brief psychiatric rating scale
42. Basic symptoms and P300 abnormalities in young schizophrenic patients
43. Effects of clozapine on awareness of illness and cognition in schizophrenia
44. P3 in schizophrenia is affected by stimulus modality, response requirements, medication status, and negative symptoms
45. Cognitive and biological determinants of P300: An integrative review
46. Psychophysiology of P300
47. Cognitive event-related potential correlates of schizophrenia
48. Delineation of pharmacopsychological effects by means of endogenous event-related brain potentials: An exemplification with flupentixol
49. Some features of the auditory evoked response in schizophrenics
50. Auditory event-related potentials in schizophrenia and depression
51. Functional differences between members of the P300 complex: P3e and P3b
52. Abnormalities in late positive components of event-related potentials may reflect a genetic predisposition to schizophrenia
53. First-episode schizophrenic psychosis differs from first-episode affective psychosis and controls in P300 amplitude over left temporal lobe
54. The effect of clozapine therapy on psychometric and event-related potential (ERP) measures of cognitive dysfunction in schizophrenia
55. The effect of clozapine therapy on frontal lobe dysfunction in schizophrenia: Neuropsychology and event-related potentials measures
56. Two bilateral sources of the late AEP as identified by a spatio-temporal dipole model
57. Correlations between abnormal auditory P300 topography and positive symptoms in schizophrenia: A preliminary report
58. Auditory event-related potentials, auditory digit span, and clinical symptoms in chronic schizophrenic men on neuroleptic medication
59. Reduced attention-related negative potentials in schizophrenic adults
60. Differences in P300 amplitudes and topography between cycloid psychosis and schizophrenia in Leonhard's classification
61. Amplitudes of auditory P300 in remitted and residual schizophrenics: Correlations with clinical features
62. The predictive value of P300-amplitudes in the course of schizophrenic disorders
63. Specific P300 features in patients with cycloid psychosis
64. 2 antagonist sulpiride on event-related potentials and its relation to the law of initial value
65. P300 subcomponent abnormalities in schizophrenia: II. Longitudinal stability and relationship to symptom change
66. P300 subcomponent abnormalities in schizophrenia: I. Physiological evidence for gender and subtype specific differences in regional pathology
67. Effects of clozapine on auditory event-related potentials in schizophrenia
68. Auditory selective attention and event-related potentials in schizophrenia